COVID-19 may not always be fighting the human body alone.
A major new study has found that severe COVID can coincide with the reactivation of viruses that have remained quietly inside the body for years. Researchers detected renewed activity from Epstein–Barr virus, cytomegalovirus, herpes simplex virus and other persistent viruses in people hospitalized with COVID-19.
The finding changes the way scientists may need to think about severe infection.
Rather than viewing COVID solely as a battle between SARS-CoV-2 and the immune system, researchers are increasingly examining a much more complicated possibility: a serious infection may disturb the body’s internal viral ecosystem enough to allow previously controlled viruses to become active again.
The study, published in Nature on August 5, 2026, followed 1,154 people hospitalized with COVID-19 across 20 U.S. hospitals. Researchers analyzed blood, nasal samples and, in mechanically ventilated patients, samples from the lower respiratory tract over periods extending as long as a year.
What they found was difficult to ignore.
Nearly Half of Hospitalized Patients Showed Viral Reactivation
Many viruses do not completely leave the body after the original infection disappears.
Epstein–Barr virus, for example, can remain inside cells after the initial infection and persist for life. Cytomegalovirus and members of the herpesvirus family can behave similarly.
Normally, the immune system keeps these viruses under control.
But severe physiological stress can change that balance.
In the new Nature study, researchers found evidence of at least one reactivated virus in 550 of 1,148 evaluable participants during the acute phase of COVID-19—about 47.9%. Most of those people had one virus detected rather than several simultaneously.
The researchers identified activity from viruses including Epstein–Barr virus, or EBV, cytomegalovirus, HSV-1, HSV-2, human herpesvirus 6 and members of the Anelloviridae family.
That does not mean every virus produced a separate obvious illness.
Reactivation can occur at a biological level without producing the classic symptoms normally associated with the original infection.
The importance lies in what that renewed activity may reveal about the immune system during severe COVID.
Epstein–Barr Virus Appeared Early
Different viruses followed different timelines.
EBV was particularly interesting because it often appeared early in the hospital course. Researchers detected EBV transcripts in about 24% of participants with samples available during days 1 through 8 after admission. Detection then declined over time.
HSV-1 and CMV behaved differently.
They tended to become detectable later during the course of illness. Among the relevant samples collected roughly 19 to 23 days after admission, HSV-1 was detected frequently in respiratory samples, while CMV appeared in a smaller proportion of blood-cell samples.
That difference suggests viral reactivation is not a single uniform process.
The viruses already living inside a person’s body may respond differently to inflammation, immune changes and the stress created by severe illness.
It also raises an intriguing question: could some complications attributed entirely to SARS-CoV-2 actually reflect interactions between several viruses and the immune system?
The study cannot yet answer that definitively.
But it makes the question much harder to ignore.
The Surprising Part Was the Immune System
One of the study’s most interesting findings challenges a common assumption about dormant-virus reactivation.
Scientists have traditionally associated reactivation strongly with immunosuppression. When immune defenses weaken severely, viruses that had been held under control can begin replicating again.
But the researchers found evidence that EBV and CMV reactivation during severe COVID was associated with systemic inflammation even among apparently immunocompetent patients.
In other words, the immune system did not necessarily have to be simply “switched off.”
A highly inflamed and dysregulated immune environment might itself contribute to the loss of control over chronic viruses.
Researchers from Boston Children’s Hospital, which participated in the study, described this as an important challenge to the assumption that viral reactivation during serious illness is mainly a consequence of weakened immunity.
That could have implications beyond COVID.
Critical illness, surgery and other major physiological stresses are already known to influence persistent viruses. Understanding exactly how inflammation changes that relationship could help researchers study complications seen across many severe illnesses.
Could Dormant Viruses Help Explain Long COVID?
This is where the research becomes especially important.
Some people recover from the acute SARS-CoV-2 infection yet continue experiencing fatigue, cognitive problems, shortness of breath, exercise intolerance and other symptoms for months or longer.
Scientists still do not believe long COVID has one simple cause.
Multiple mechanisms are under investigation, including persistent viral material, immune dysregulation, vascular changes, autoimmunity and reactivation of latent viruses.
The 2026 study adds new evidence to that final possibility.
Researchers found that reactivation was not limited to the hospital period. Evidence of some viral activity persisted during recovery, and Anelloviridae reactivation was associated with long COVID and later physical disability.
Anelloviruses are particularly interesting because they are extremely common and usually attract little attention. Nature reported that their reactivation appeared linked with the development of long COVID in the study population.
Does that prove these viruses cause long COVID?
No.
The researchers explicitly state that the study establishes associations rather than causation. A person with more severe COVID might experience both greater viral reactivation and worse long-term outcomes because of another underlying biological process.
That distinction matters.
The findings identify a potential clue, not a completed explanation.
Why Dormant Viruses Can Stay Hidden for Decades
Persistent viruses have developed remarkably effective strategies for remaining inside human hosts.
Herpesviruses are among the best-known examples. After initial infection, they can enter a latent state in particular cells rather than continuously producing large quantities of new virus.
The immune system generally keeps that latent infection under control.
But latency is not the same as eradication.
Stress, illness, hormonal changes, surgery, sleep disruption and other physiological disturbances can sometimes allow these viruses to reactivate. The Nature researchers note that chronic viral infections are widespread and that reactivation under physiological stress is a known phenomenon.
COVID may therefore be exposing something that was already present rather than introducing every biological problem itself.
That is a fundamentally different way of thinking about infection.
A new virus may enter the body and disturb an existing network of microorganisms, immune responses and latent infections.
The resulting illness could reflect the interaction between all of them.
The Study Was Large, but It Still Has Important Limits
The research is unusually comprehensive, involving more than 1,100 hospitalized patients and extensive genomic, immune, protein and metabolic measurements.
However, the participants were enrolled between May 2020 and March 2021.
Every participant was vaccine-naive at enrollment, meaning the study largely reflects an earlier phase of the pandemic before widespread vaccination and before later SARS-CoV-2 variants reshaped population immunity.
That means researchers still need to determine how closely the findings apply to people infected under today’s very different immunological conditions.
The study also focused on hospitalized patients rather than typical mild outpatient infections.
Its findings therefore should not be interpreted as evidence that every COVID infection causes dormant viruses to reactivate.
Severity appears to matter.
The Bigger Discovery May Be How Complex Viral Illness Really Is
The most important lesson from this research may extend beyond COVID.
Humans carry an enormous biological history inside them.
Some previous viral infections are eliminated. Others remain quietly embedded within cells or tissues, often causing no obvious problem for decades.
A severe new illness can potentially disturb that equilibrium.
The 2026 Nature study suggests that severe COVID frequently coincided with renewed activity from persistent viruses and that those reactivations were connected with inflammation, disease severity and longer-term outcomes.
Scientists now need to determine whether those viruses are merely markers of a severely stressed immune system or whether they actively contribute to worsening disease.
That distinction could eventually matter for diagnostics and treatment.
If particular reactivations turn out to drive complications rather than merely accompany them, researchers could investigate whether existing antiviral therapies or more targeted immune treatments have a role.
For now, the discovery offers something more fundamental.
COVID may not always represent one virus attacking one patient.
In severe disease, it may disturb an entire hidden viral ecosystem that has been living inside that person all along.
